FDA approves abemaciclib for advanced breast cancerSeptember 28, 2017Breast CancerMetastatic Breast Cancer
HER2 status differed between primary tumor and CTCs in 18.8% of women with MBCSeptember 28, 2017Breast CancerMetastatic Breast Cancer
Two cases of possible remission in metastatic triple-negative breast cancerSeptember 28, 2017Breast Cancer
GEICAM/2006-10: Adjuvant fulvestrant/anastrozole role in early breast cancer uncertainSeptember 25, 2017Breast Cancer
‘Very daring study’ of neoadjuvant AI/CDKi combo in early BC is hypothesis generatingSeptember 23, 2017Breast Cancer
LORELEI sings praises of neoadjuvant taselisib/letrozole in ER+/HER2– breast cancerSeptember 15, 2017Breast Cancer
Surgeons strongly influenced chances of contralateral prophylactic mastectomySeptember 13, 2017Breast Cancer
Ten-year outcomes support skipping axillary lymph node dissection with positive sentinel nodesSeptember 12, 2017Breast Cancer
Assessing a multidisciplinary survivorship program in a group of predominantly Hispanic women with breast cancerSeptember 8, 2017Breast Cancer
FDA clears first 2D mammography device with patient-controlled compressionSeptember 6, 2017Breast Cancer
